DemetriusMMaraganoreMDFAAN

Movement Disorder, Neurodegenerative, Dementia & Geriatrics

Chair of the Department of Neurology, Professor of Neurology, Herbert J. Harvey, Jr. Chair in Neurosciences, Co-director of the Tulane Center for Clinical Neurosciences, Tulane University School of Medicine; Faculty Member, Tulane Brain Institute and Tulane Center on Aging, Tulane University

Join to view full profile

Dr. Maraganore is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Maraganore's full profile

Already have an account?

Office
101 Judge Tanner Blvd Ste 402
Covington, LA 70433
Phone+1 985-951-3222

Fax+1 985-951-3223

Summary

Dr. Maraganore's passion is helping patients to achieve successful brain aging by preventing cognitive decline and dementia.

His recent research studies relate to: 1) quality improvement and practice-based research in neurology using the electronic medical record (EMR); 2) utilizing data from the EMR to predict Alzheimer's and dementia risk; and 3) understanding resistance, resilience, and repair in the health span ("over 90's study"). His clinical practice is in brain health (primary prevention of cognitive decline and dementia in at-risk persons) and the evaluation and management of memory disorders (including mild cognitive impairment and dementia).

Dr. Maraganore is the past BJ and Eve Wilder Professor of Alzheimer's Disease at the University of Florida, and recent founder and Director of the University of Florida Brain Health Program. Before the University of Florida, he was the Chair of Neurology at NorthShore University Health System and the Mayo Clinic Chair of the Division of Movement Disorders.

A Chicago native, Dr. Maraganore received his Bachelor of Science and Medical Degree at Northwestern University. He then completed his internship and residency at the Mayo Clinic in Rochester, MN. He was then the Honorary Clinical and Research Fellow to Professor C. David Marsden at the National Hospital for Neurology and Neurosurgery in London, England.

His clinical practice is in brain health (primary preventions of cognitive decline and dementia), and in mild cognitive impairment, Alzheimer's disease, and related dementias.

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Residency, Neurology, 1985 - 1989
Northwestern University The Feinberg School of MedicineClass of 1985
Northwestern UniversityB.S., 1983

Certifications & Licensure

LA State Medical License 2020 - 2025
MS State Medical License 2021 - 2025
IL State Medical License 2009 - 2023
FL State Medical License 2018 - 2022
MN State Medical License 1986 - 2021
American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

Herbert J. Harvey, Jr. Chair in Neurosciences Tulane University, 2020
Chair, State Health Improvement Plan (Priority Area 9, Alzheimer's Disease and Related Disorders), subcommittee on risk factors and disparities State of Florida, 2019
B.J. and Eve Wilder Professor of Alzheimer's Disease University of Florida, 2018
Chicago Magazine: Top Doctors Castle Connolly, 2016
Fellow American Academy of Neurology, 2015
Chicago Magazine: Top Doctors Castle Connolly, 2014
America's Top Doctors Castle Connolly, 2010-2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Recipient of the Paul Silverstein Community Service Award 2007
Scholarship Mayo Foundation, 1989
Super Doctor SuperDoctors.com
Join now to see all

Clinical Trials

Molecular Epidemiology of Parkinson's Disease Start of enrollment: 2000 Sep 01
Completed
Imaging Biomarkers of Delayed Sequelae in Trauma Brain Injury Start of enrollment: 2012 Mar 01
Completed
Quality Improvement and Practice Based Research in Neurology Using the EMR Start of enrollment: 2016 May 01
Enrolling by invitation
Phase 4

Publications & Presentations

PubMed

The impact of gut microbiome and diet on post-acute sequelae of SARS-CoV-2 infection.
Zabrina Reyes, Mary Catherine Stovall, Sanjana Punyamurthula, Michele Longo, Demetrius Maraganore
Journal of the Neurological Sciences. 2024-12-15
Lipid trajectories improve risk models for Alzheimer's disease and mild cognitive impairment.
Bruce A Chase, Roberta Frigerio, Chad J Yucus, Smita Patel, Demetrius Maraganore
Journal of Lipid Research. 2024-11-23
An Integrative Migraine Polygenic Risk Score Is Associated with Age at Onset But Not Chronification.
Bruce A Chase, Roberta Frigerio, Susan Rubin, Tiffani Franada, Irene Semenov
Journal of Clinical Medicine. 2024-10-29

Journal Articles

Structured Clinical Documentation to Improve Quality and Support Practice‐Based Research in Headache
Franco Campanella, Susan Rubin, Steven Meyers, Angela Mark, Demetrius M Maraganore, Thomas Freedom, Irene Semenov, Headache: The Journal of Head and Face Pain
In Memorium - Nicholas A Vick, MD
McMahon JP, Groothuis DR, Homer D, Maraganore DM, Neurology, 1/10/2015
Large Scale Assessment of Polyglutamine Repeat Expansions in Parkinson Disease
Wang L, Aasly JO, Annesi G, Bardien S, Bozi M, Brice A, Carr J, Chung SJ, Clarke C, Crosiers D, Deutschlander A, Eckstein G, Farrer MJ, Goldwurm S, Garraux G, Hadjige..., Neurology, 1/9/2015
Contemporary Issues in Neurological Practice – Quality Improvement and Practice-Based Research in Neurology Using the Electronic Medical Record
Maraganore DM, Frigerio R, Kazmi N, Meyers SL, Sefa M, Walters SA, Silverstein JC, Neurology Clinical Practice, 1/1/2015
Role for the microtubule-associated protein tau variant pA152T in risk of A-synucleinopathies
Labbe C, Ogaki K, Lorenzo-Betancor O, Soto-Ortolaza AI, Walton RL, Rayaprolu S, Fujioka S, Murray ME, Heckman MG, McCarthy A, Lynch T, Siuda J, Opala G, Rudzinska M, K..., Neurology, 1/1/2015
MAPT haplotype H1G is associated with increased risk of dementia with Lewy bodies
Ross O, Labbe C, Heckman MG, Lorenzo-Betancor O, Soto-Ortolaza AI, Walton RL, Murray ME, Allen M, Uitti RJ, Wszolek ZK, Smith GE, Kantarci K, Knopman D, Lowe VJ, Jack ..., Alzheimer’s and Dementia, 1/1/2015
Genome-Wide Gene-Environment Interaction Analysis of Pesticide Exposure and Risk of Parkinson’s Disease
JM Biernacka JM, Chung SJ, Armasu SM, Anderson KS, Lill CM, Bertram L, Ahlskog JE, Brighina L, Frigerio R, Maraganore DM, JM Biernacka JM, Chung SJ, Armasu SM, Anderson KS, Lill CM, Bertram L, Ahlskog JE, Brighina L, Frigerio R, Maraganore DM, 1/1/2015
Alpha-synuclein REP1 variants and survival in Parkinson's disease
Chung SJ, Biernacka J, Armasu S, Anderson K, Frigerio R, Aasly J, Annesi G, Bentivoglio AR, Brighina L, Chartier-Harlin MC, Goldwurm S, Hadjigeorgiou G, Jasinska-Myga..., Movement Disorders, 1/1/2014
Does A-Synuclein Have A Dual and Opposing Effect in Preclinical versus Clinical Parkinson's Disease?
Markopoulou K, Biernacka J, Armasu S, Anderson K, Ahlskog JE, Chase B, Chung SJ, Cunningham J, Farrer M, Frigerio R, Maraganore D, Parkinsonsim and Related Disorders, 1/1/2014
Lack of Replication of the GRIN2A-by-Coffee Interaction in Parkinson’s Disease
Ahmed I, Lee P-C, Lill CM, Nielsen SS, Artaud F, Gallagher LG, Loriot M-A, Mulot C, Nacfer M, Liu T, Biernacka JM, Armasu S, Anderson K, Farin FM, Lassen CF, Hansen J,..., PLOS Genetics, 1/1/2014
Population-specific frequencies for LRRK2 susceptibility variants in the Genetic Epidemiology of Parkinson’s Disease (GEO-PD) consortium
Heckman MG, MS1, Alexandra I. Soto-Ortolaza AI, Aasly JO, Abahuni N, Annesi G, Bacon JA, Bardien S, Bozi M, Brice A, Brighina L, Carr J, Chartier-Harlin M-C, Dardiotis..., Movement Disorders, 1/1/2013
Genetic susceptibility loci, environmental exposures and Parkinson’s disease: a case-control study of gene-environment interactions
Chung SJ, Armasu SM, Anderson KJ, Biernacka JM, Lesnick TG, Rider, DN, Cunningham JM, Ahlskog JE, Frigerio R, Maraganore, DM, Parkinsonism and Related Disorders, 1/1/2013
'The Protective Effect of LRRK2 pR1398H on Risk of Parkinson's Disease is Independent of MAPT and SNCA Variants
Heckman MG, Elbaz A, Soto-Ortolaza AI, Serie DJ, Aasly JO, Annesi G, Auburger G, Bacon JA, Boczarska-Jedynak M, Bozi M, Brighina L, Chartier-Harlin M-C, Dardiotis E, D..., Neurobiology of Aging, 1/1/2013
Evidence for a Dual and Opposing Effect of alpha-Synuclein Genetic Variation in Preclinical versus Clinical Parkinson’s Disease
Markopoulou K, Biernacka J, Armasu S, Anderson K, Ahlskog JE, Chase B, Chung SJ, Cunningham J, Farrer M, Frigerio R, Maraganore DM, Brain, 1/1/2013
Global investigation of the C9orf72 (G4C2)n hexanucleotide repeat reveals a role in Parkinson disease susceptibility
Theuns J, Verstraeten A, Sleegers K, Wauters E, Gijselinck I, Crosiers D, Corsmit E, Elinck E, Sharma M, Krüger R, Lesage S, Brice A, Chung SJ, Kim M-I, Kim YJ, Ross O..., The Lancet Neurology, 1/1/2013
Mutations in ClZ1 cause adult-onset primary cervical dystonia
Xiao J, Uitti R, Zhao Y, Vemula SR, Perlmutter JS, Wszolek ZK, Maraganore DM, Auburger G, Leube B, Lehnhoff K, LeDoux MS, Annals of Neurology, 1/1/2012
Comprehensive research synopsis and systematic meta-analyses in Parkinson’s disease genetics: The PDGene Database
Lill CM, Roehr JT, McQueen MB, Kavvoura FK, Bagade S, Schjeide B-MM, Schjeide LM, Meissner E, Zauft U, Allen, NC, Beecham G, Berg D, Brice A, DeStefano AL, Do CB, Erik..., PLoS Genetics, 1/1/2012
Genomic Determinants of Motor and Cognitive Outcomes in Parkinson’s Disease
Chung SJ, Armasu S, Biernacka J, Anderson K, Lesnick T, Rider D, Cunningham J, Ahlskog JE, Frigerio R, Maraganore DM, Parkinsonism and Related Disorders, 1/1/2012
Translation Initiator eIF4G1 mutations in familial Parkinson disease
Chartier-Harlin M-C, Dachsel JC, Vilariño-Güell C, Lincoln SJ, Hulihan MM, Kachergus J, Leprêtre F, LeRhun E, Mutez E, Larvor L, Ross OA, Nishioka K, Soto-Ortolaza AI,..., The American Journal of Human Genetics, 1/9/2011
Variants in estrogen-related genes and risk of Parkinson’s disease
Chung SJ, Armasu SM, Biernacka JM, Lesnick TG, Rider DN, Cunningham JM, Maraganore DM, Movement Disorders, 1/1/2011
Common Variants in PARK Loci and Related Genes and Parkinson's Disease
Chung SJ, Armasu SM, Biernacka JM, Lesnick TG, Rider DN, Lincoln SJ, Ortolaza AI, Farrer MJ, Cunningham JM, Rocca WA, Maraganore DM, Movement Disorders, 1/1/2011
Perimenopausal Risk Factors and Future Health
The ESHRE Capri Workshop Group, Human Reproduction Update, 1/1/2011
Incidental Lewy Body Disease: Do Some Cases Represent a Preclinical Stage of Dementia with Lewy Bodies?
Frigerio R, Fujishiro H, Ahn T-B, Josephs KA, Maraganore DM, DelleDonne A, Parisi JE, Klos KJ, Boeve BF, Dickson DW, Ahlskog JE, Neurobiology of Aging, 1/1/2011
Independent and joint effects of the MAPT and SNCA genes in Parkinson’s disease
Elbaz A, Ross OA, Ioannidis JPA, Soto-Ortolaza AI, Moisan F, Aasly J, Annesi G, Bozi M, Brighina L, Chartier-Harlin M-C, Destee A, Ferrarese C, Ferraris A, Gibson JM, ..., Annals of Neurology, 1/1/2011
Do Interactions Between SNCA, MAPT, and LRRK2 Genes Contribute to Parkinson’s Disease Susceptibility?
Biernacka J, Armasu S, Cunningham J, Ahlskog JE, Chung SU, Maraganore D, Parkinsonism and Related Disorders, 1/1/2011
Join now to see all

Books/Book Chapters

Parkinson's Disease and Movement Disorders
Chapter: Epidemiology and Genetics of Parkinson's Disease
Maraganore DM, Adler CH, Ahlskog JEHumana Press, Totowa NJ2000

Abstracts/Posters

Data Collection and Principal Component Analysis in Migraine Without and With Aura: A Practical Method of Combining Patient Care with Outcomes Research
Freedom T, Meyers S, Rubin S, Semenov I, Mark A, Walters S, Frigerio R, Maraganore D, Headache: The Journal of Head and Face Pain, Special Issue: 57th Annual Scientific Meeting of the American Headache Society, 1/1/2015
Automated Segmentation of Substantia Nigra - Improved Reliability for Multiparametric MR Measurements
Hutten R, Desai N, Maraganore D, Edelman RR, Wu Y, Proceedings of the 23rd Annual Meeting of the International Society for Magnetic Resonance in Medicine, Milan, Italy, 1/16/2014
Reliable Analysis of Tract-specific Multiparametric MR Data via Automated Isolation of Nigro-striatal Tract
Hutten R, Desai N, Maraganore D, Edelman RR, Wu Y, Proceedings of the 23rd Annual Meeting of the International Society for Magnetic Resonance in Medicine, Milan, Italy, 1/16/2014
Evaluation of the Genetic Contribution of Omi/HtrA2 to Parkinson's Disease in an International Collaborative Study
Kruger R, Sharma M, Riess O, vanBroeckhoven C, Maraganore DM, Aasly J, Annesi G, Bentivoglio AR, Brice A, Elbaz A, Farrer M, Ferrarese C, Ferraris A, Hadjigeorgiou G, ..., Movement Disorders, Tuebingen, Germany, 1/1/2009
Reduced Bowel Movements Preceding Parkinson's Disease: A Case-Control Study
Savica R, Grossardt BR, Carlin JM, Bower JH, Ahlskog JE, Maraganore DM, Rocca WA, Movement Disorders, 1/1/2009
Prospective Differentiation of Multiple System Atrophy from Parkinson's Disease
Lipp A, Paola S, Eric A, Fealey RD, Gehrking TL, Weigand SD, Sletten DM, Gehrking JA, Nickander KK, Singer W, Maraganore DM, Wenning GK, Shults CM, Low PA, Movement Disorders, 1/1/2009
Novelty Seeking Personality Traits Do Not Influence the Risk of Parkinson's Disease
Arabia G, Grossardt BR, Colligan RC, Bower JH, Maraganore DM, Ahlskog JE, Rocca WA, Movement Disorders, 1/1/2009
Cigarette smoking, CYP2A6 gene variants, and Parkinson’s Disease: A Case-Control Study
Facheris MF, Schneider NK, Lesnick TG, de Andrade M, Kost LJ, Cunningham JM, Rocca WA, Maraganore DM, Movement Disorders, 1/1/2008
Secondary Parkinsonism and a Distorted Midbrain
Claassen DO, Burnett MS, Huston J, Maraganore DM, Movement Disorders, 1/1/2008
Joint Effects of Alpha-Synuclein and Beta-Synuclein Genes in Parkinson's Disease
Brighina L, Okubadego NU, Schneider NK, Lesnick TG, de Andrade M, Cunningham JL, Farrer MJ, Rocca WA, Maraganore DM, Neurology, 1/1/2007
Increased Risk of Anxiety, Depression, and Other Psychiatric Disorders in Relatives of Patients with Parkinson's Disease: A Population-Based Cohort Study
Arabia G, Bower JH, Ahlskog JE, Maraganore DM, Geda YE, Grossardt BR, Carlin JM, Rocca WA, Neurology, 1/1/2007
Multiregional High-Throughput Gene Expression Profiling of Braak Regions in Parkinson's Disease
Papapetropoulos S, Maraganore DM, Ffrench-Mullen J, McCorquodale D, Adi N, Mash DC, Neurology, 1/1/2007
Alcoholism, Alpha-Synuclein, and Parkinson Disease: A Case-Control Study
Brighina L, Schneider NK, Lesnick TG, de Andrade M, Cunningham JM, Farrer MJ, Lincoln SJ, Mrazek D, Rocca WA, Maraganore DM, Parkinson’s Disease and Related Disorders, 1/1/2007
Increased Risk of Depressive and Anxiety Disorders in Relatives of Patients with Parkinson’s Disease
Arabia G, Grossardt BR, Geda YE, Carlin JM, Bower JH, Ahlskog JE, Maraganore DM, Rocca WA, Parkinson’s Disease and Related Disorders, 1/1/2007
Collaborative-pooled analysis of alpha-synuclein REP1 variability and Parkinson's disease
Maraganore DM, American Academy of Neurology, San Francisco, CA, 1/1/2006
The Mayo Clinic Cohort Study of Oophorectomy and Aging: Design and Follow-Up Description
Grossardt BR, Bower JH, de Andrade M, Maraganore DM, Melton, LJ, Rocca WA, Neuroepidemiology, 1/1/2006
Collaborative-Pooled Analysis of alpha-Synuclein REP1 Variability and Parkinson's Disease (PD)
WA, Schneider N, LEsnick T, Aasly J, Ashizawa T, Chartier-Harlin MC, Checkoway H, Ferrarese C, Hadjigeorgiou G, Hattori N, Kawakami H, Lambert JC, Lynch T, Mellick G, ..., Neurology, 1/1/2006
Variants in Genes in the Estrogen Synthesis and Responsiveness Pathway and Risk of Parkinson's Disease: A Case-Control Study in Women
Rocca WA, Grossardt B, de Andrade M, Bower JH, Maraganore DM, Neurology, 1/1/2006
The Mayo Clinic Cohort Study of Oophorectomy and Aging: Results for Dementia and Cognitive Impairment
Rocca W, Grossardt B, Ahlskog E, Bower J, de Andrade M, Maraganore DM, Neurology, 1/1/2006
Education, Physically Demanding Occupations, and the Risk of Parkinson's Disease
Frigerio R, Bower J, Ahlskog E, Grossardt B, de Andrade M, Maraganore DM, Rocca WA, Neurology, 1/1/2006
High-Resolution Whole-Genome Association Study of Age at Onset Modifier Genes and Parkinson's Disease
Maraganore DM, de Andrade M, Lesnick T, Farrer M, Rocca W, Neurology, 1/1/2006
A novel LRRK2 mutation in a common cause of autosomal dominant parkinsonism in families from several European populations
Toft M, Kachergus J, Mata IF, Hulihan M, Aasly J. Farrer M, Maraganore DM, Mov Disord, 1/1/2005
Parkinson's disease in Africa: a systematic review
Okubadejo NU, Bower JH, Rocca WA, Maraganore DM, Mov Disord, 1/1/2005
Discordant Sibling Analyses Confirm the Association of UCHL1 with Parkinson’s Disease
Maraganore DM, Facheris M, Lesnick TG, Strain KJ, de Andrade M, Cunningham JM, Rocca WA, Neurology, 1/1/2005
Interaction of Alpha-Synuclein and Tau Genotypes in Parkinson’s Disease
Maraganore DM, Mamah CE, Lesnick TG, Strain KJ, de Andrade M, Rocca WA, Farrer MJ, Neuroepidemiology, 1/1/2005
Join now to see all

Lectures

Paradigm Shift: from Brain Disorders to Brain Health
1/27/2015
Quality Improvement and Practice Based Research in Neurology Using the Electronic Medical Record
1/18/2015
Genetic Epidemiology of Parkinson’s Disease Consortium Updates
Vancouver, Canada - 1/1/2014
The LONG-PD Study: Longitudinal Clinical and Genetic Study of Parkinson’s Disease
Vancouver, Canada - 1/1/2014
Clinical and Research Informatics in Neurology: the DodoNA Project
1/24/2013
Genetic Epidemiology of Parkinson’s Disease Consortium
Luebeck, Germany - 1/1/2013
Research Electronic Data Capture and Sharing of Outcomes Data and DNAs in PD
Luebeck, Germany - 1/1/2013
SNCA reduced expression genotypes and survival in PD
Multiple Locations, 2010, 2011, 2012 - 1/1/2012
Datablitz Presentation
Multiple Locations, 2009, 2010, 2012 - 1/1/2012
Introduction to GEO-PD
Multiple Locations, 2009, 2010, 2011, 2012 - 1/1/2012
Back to the Future: from Greek Oracles to DNA Prediction
Seoul, Korea - 1/1/2012
Lifestyles and the Aging Brain: the Example of Parkinson’s Disease
Capri, Italy - 1/30/2010
Rationale for Targeting Alpha-Synuclein in Parkinson's Disease
Monza, Italy - 1/15/2010
The DodoNA Project: Development of DNA-based Prognostics and Therapeutics for Neurological Diseases
Seoul, South Korea - 1/1/2010
New Insights in Understanding and Treating Parkinson’s Disease: Rationale for Targeting alpha-Synuclein
Busan, Korea - 1/1/2010
Genomic Determinants of Motor and Cognitive Outcomes in Parkinson's Disease
Lombardy, Italy - 1/1/2009
Pathways to complexity: genomic pathway studies in PD
Trondheim, Germany - 1/1/2009
Pathways to Complexity: The Examples of Parkinson's Disease, Alzheimer's Disease, and ALS
1/1/2009
Genetics of Complex and Common Disorders
Seattle, WA - 1/1/2009
The Genetic Epidemiology of Parkinson's Disease Consortium and Pathways-Based Analyses of PD GWA Datasets
Washington, DC - 1/24/2008
Genomic Pathways, Environmental Exposures, and Disease Susceptibility: The Example of Parkinson’s Disease
Boston, MA - 1/16/2008
Overview of the Genetic Epidemiology of Parkinson’s Disease Consortium
Trondheim, Norway - 1/1/2008
GEO-PD Data Blitz
Trondheim, Norway - 1/1/2008
Pathways to Complexity
Trondheim, Norway - 1/1/2008
Paradigm Shift: From Single Gene to Pathway Studies of Complex Traits (The Example of Parkinson's disease)
Monza, Italy - 1/10/2007
Join now to see all

Press Mentions

Healthy Brain Aging Initiative Aims to Promote ‘Super Aging’July 19th, 2024
Blood Tests and a New Promising Drug for Alzheimer’s Are Here. Here’s What You Need to KnowDecember 2nd, 2022
Is It Alzheimer’s? Families Want to Know, and Blood Tests May Offer AnswersNovember 17th, 2022
Join now to see all

Grant Support

Understanding Resistance, Resilience and Repair in the Health Span: The Over 90 MoonshotUF Moonshot Award2019–Present
Utilizing Data from the Electronic Medical Record to Predict Alzheimer's and Dementia RiskFlorida Department of Health (Ed and Ethel Moore Grant)2019–Present
Quality Improvement and Practice Based Research in Neurology Using the EMRAgency for Healthcare Research and Quality2015–Present
Molecular Epidemiology Of Parkinson'S DiseaseNational Institute Of Environmental Health Sciences2010
Molecular Epidemiology Of Parkinson'S DiseaseNational Institute Of Environmental Health Sciences2004–2009
Feasibility Study Of Fluorodopa PET In The Early Detection Of Parkinson'SNational Center For Research Resources2005
Fluorodopa PET In Early Detection Of Parkinson'S DiseaseNational Center For Research Resources2004
Supplement-Es10751 (Molecular Epidemiology Of Pd)National Institute Of Environmental Health Sciences2003
Molecular Epidemiology Of Parkinson'S DiseaseNational Institute Of Environmental Health Sciences2000–2003

Committees

Member, American Academy of Neurology Registry Committee 2015 - Present
Founding Director, Neurology Practice Based Research Network 2015 - Present

Research History

Herbert J. Harvey, Jr. Chair in NeurosciencesMy clinical research is in brain health (primary prevention of cognitive decline and dementia). My approaches include using the electronic medical record to predict Alzheimer's and related dementias and to identify cohorts of cognitive super agers, and lifestyle and behavioral interventions.2020 - Present
B.J. and Eve Wilder Professor of Alzheimer's DiseaseClinical and research program in preventing cognitive decline and dementia (Brain Health).2018 - Present
Ruth Cain Ruggles Chair of NeurologyQuality Improvement and Practice Based Research in Neurology Using the Electronic Medical Record The DodoNA Project: DNA Predictions to Improve Neurological Health2009 - 2018
Professor of Neurology, Chair of the Division of Movement Disorders, Mayo Clinic, Rochester, MN1990 - 2009

Professional Memberships

Other Languages

Greek, Italian

External Links

Tulane Clinical Neuroscienceshttps://medicine.tulane.edu/centers-institutes/tulane-center-clinical-neurosciences
Facebook pagehttps://www.facebook.com/TulaneNeurosciences
Biohttps://medicine.tulane.edu/departments/neurology/faculty/demetrius-m-maraganore-md-faan